Clinical Trial Update: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

View source ↗

Summary

This clinical trial update reports on the tolerance of Nivestim (filgrastim) in patients treated with highly toxic chemotherapeutic regimens, based on a complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Malignant Hematologic Diseases
• Solid Tumors

Drugs mentioned

• Nivestim (filgrastim)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Solid Tumors, Malignant Hemopathy | Status: COMPLETED